Fact CheckerSign in

NCT05546281Completed

Study of the Characteristics of Orthorexia Nervosa in the Population Living with Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 9 Oct 2024

Brief summary (registry, in English)

In the general population, the excessive and constant desire to control one's diet and body has become increasingly problematic. Indeed, the demand for control over one's diet and body is now an unspoken social prescription that can lead in some cases to eating disorders. In patients with type 1 diabetes (T1D), these concerns are even more central, as they are accentuated by the very nature of the treatment of the disease (dietary modification, insulin compensation according to food intake, etc.). Studies on adolescents with T1D show that the prevalence of eating disorders would be present in at least 1 in 5 patients. Among these disorders, orthorexia is of particular interest. Indeed, orthorexia was defined in 1997 by Steven Bratman as a rigid eating behavior based on the avoidance of foods considered qualitatively unhealthy. More precisely, orthorexia is characterized by a constant preoccupation with one's diet and persistent nutritional (or health) beliefs that take precedence over food pleasure. It has been estimated that the prevalence of orthorexia in patients living with T1D may be as high as 80%. We are currently conducting a study on the mechanisms of orthorexia in the general population of Quebec (the results of phase 1 of this study are being analyzed). We now wish to conduct the same study in a population with T1D, which has a higher prevalence of people with orthorexia nervosa. The main objective of this study is to investigate the characteristics of orthorexia nervosa (obsessions and fixations on healthy eating) in the Quebec population with T1D from the BETTER Registry.

Status (registry)
Completed
Study type
Observational
Enrollment
33 (actual)
First submitted
16 Sept 2022
Start date
1 Oct 2022
Primary completion date
1 Apr 2024
Lead sponsor
Laval University
NCT number
NCT05546281

What you commit to

  • Study type: Observational
  • Participants enrolled: 33
  • From 1 Oct 2022 to the primary completion date, 1 Apr 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Person living with type 1 diabetes
  • French speaking
  • Between 18 and 35 years old

Age in the registry: 18 years to 35 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status
IUCPQ
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.